Financials data is unavailable for this security.
View more
Year on year Shanghai OPM Biosciences Co Ltd 's revenues fell -17.41% from 294.37m to 243.12m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 105.37m to 54.04m, a -48.72% decrease.
Gross margin | 57.66% |
---|---|
Net profit margin | 14.86% |
Operating margin | 18.46% |
Return on assets | 1.73% |
---|---|
Return on equity | 1.87% |
Return on investment | 1.78% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Shanghai OPM Biosciences Co Ltd fell by 223.64m. However, the company earned 57.95m from its operations for a Cash Flow Margin of 23.84%. In addition the company used 149.53m on investing activities and also paid 133.01m in financing cash flows.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 18.70 |
---|---|
Tangible book value per share | 18.36 |
More ▼
Balance sheet in CNYView more
Current ratio | 20.86 |
---|---|
Quick ratio | 20.08 |
Total debt/total equity | 0.0339 |
---|---|
Total debt/total capital | 0.0328 |
More ▼